|
SEC24B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62318999999966E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06130000000027E-05 |
| Normal-vs-Stage2 |
2.362000E-01 |
| Normal-vs-Stage3 |
3.579600E-02 |
| Normal-vs-Stage4 |
2.696200E-01 |
| Stage1-vs-Stage2 |
2.510200E-01 |
| Stage1-vs-Stage3 |
7.042800E-01 |
| Stage1-vs-Stage4 |
6.915000E-01 |
| Stage2-vs-Stage3 |
4.874400E-01 |
| Stage2-vs-Stage4 |
6.905200E-01 |
| Stage3-vs-Stage4 |
8.946000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96530999999611E-05 |
| Normal-vs-AfricanAmerican |
4.221200E-03 |
| Normal-vs-Asian |
4.802600E-04 |
| Caucasian-vs-AfricanAmerican |
7.139800E-01 |
| Caucasian-vs-Asian |
4.627600E-01 |
| AfricanAmerican-vs-Asian |
3.709000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50650000030339E-07 |
| Normal-vs-Female |
2.678800E-01 |
| Male-vs-Female |
4.861400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.083000E-03 |
| Normal-vs-Extreme_Weight |
2.79960000004742E-06 |
| Normal-vs-Obese |
3.058000E-02 |
| Normal-vs-Extreme_Obese |
1.080120E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.590000E-01 |
| Normal_Weight-vs-Obese |
3.534400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.761400E-01 |
| Extreme_Weight-vs-Obese |
5.214400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.941600E-01 |
| Obese-vs-Extreme_Obese |
3.051000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.079000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.243660E-02 |
| Normal-vs-Age(61-80Yrs) |
2.34130000054122E-07 |
| Normal-vs-Age(81-100Yrs) |
4.375700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.797800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.393200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.060000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.371860E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.553810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.948400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.11090000004732E-06 |
| Normal-VS-Type2 PRCC |
8.597600E-04 |
| Normal-VS-KIRP CIMP |
4.383200E-01 |
| Normal-VS-Unclassified PRCC |
1.423410E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.167200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.475200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.042800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.640000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.731200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.894200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.20920000024461E-07 |
| Normal-vs-N1 |
1.091170E-01 |
| Normal-vs-N2 |
9.214400E-01 |
| N0-vs-N1 |
2.050400E-01 |
| N0-vs-N2 |
1.167580E-01 |
| N1-vs-N2 |
5.802200E-01 |
|
|
